See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061027_2023_Viracta_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001061027, Viracta Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 93,747,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 148,000 |
| 3 | remainder_Assets | 2,096,000 |
| 4 | LiabilitiesCurrent | 10,011,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,327,000 |
| 9 | ResearchAndDevelopmentExpense | 26,262,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,392,000 |
| 13 | remainder_ComprehensiveNetIncome | -178,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 95,991,000 |
| 1 | Liabilities | 10,011,000 |
| 2 | Expenses | 50,589,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 85,980,000 |
| 5 | NetIncome | -49,197,000 |
| 6 | ComprehensiveNetIncome | -49,286,000 |
| 7 | BaseVar | 79,080,500 |
| 8 | EconomicCapitalRatio | 1.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
